YTX-465
YTX-465 is a stearoyl-CoA desaturase (Ole1/SCD) inhibitor. YTX-465 inhibits Ole1 and SCD1 with IC50s of 0.039 μM and 30.4 μM, respectively. YTX-465 can be used in the research of Parkinson’s disease and other synucleinopathies[1].
Product Specifications
CAS Number
[2225824-53-1]
UNSPSC
12352005
Target
Stearoyl-CoA Desaturase (SCD)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ytx-465.html
Purity
99.06
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NCC(N1CCC(C2=NC(C3=CC4=C(C=C3)C(C)=NN4C)=NO2)CC1)=O)C5=CC=CC=C5
Molecular Formula
C25H26N6O3
Molecular Weight
458.51
References & Citations
[1]Vincent BM, et al. Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity. Cell Rep. 2018 Dec 4;25 (10) :2742-2754.e31.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
VMAT2 (SLC18A2, Solute Carrier Family 18 (Vesicular Monoamine) Member 2, SVAT, SVMT, Synaptic Vesicle Amine Transporter Brain, Synaptic Vesicle Monoamine Transporter Brain, VAT2, Vesicular Amine Transporter 2, Vesicular Monoamine Transporter 2, VMAT2) (Not for Export EU)
CREBBP, NT (CREB-binding protein, CREBBP, CBP, KAT3A) (MaxLight 750)
CREBBP, NT (CREB-binding protein, CREBBP, CBP, KAT3A) (MaxLight 750)
